Trial intelligence / Profile preview

Phase 3 Study of Numbrino (Cocaine HCl) for Nasal Anesthesia

NCT02500836Phase 3Completed

Sponsor
Lannett
Start
Sep 2015
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of nifedipine in pain, sponsored by Lannett. Started Sep 2015; status: completed.

02

Drugs

nifedipine
03

Conditions

pain

Beyond the preview

Go deeper on NCT02500836.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02500836.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call